Bioventix Plc Holding(s) in Company
July 21 2021 - 11:27AM
UK Regulatory
TIDMBVXP
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the
FCA in Microsoft Word format if possible)i
1a. Identity of the issuer or the underlying BIOVENTIX PLC
issuer of existing shares to which voting
rights are attachedii:
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X"
if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with
an "X")
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify)iii:
3. Details of person subject to the notification obligationiv
Name CANACCORD GENUITY GROUP INC
City and country of registered office (if VANCOUVER, CANADA
applicable)
4. Full name of shareholder(s) (if different from 3.)v
Name DISCRETIONARY CLIENTS
City and country of registered office (if As above
applicable)
5. Date on which the threshold was crossed or 16 JULY 2021
reachedvi:
6. Date on which issuer notified (DD/MM/YYYY): 19 JULY 2021
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both in Total number of
rights attached through financial % (8.A + 8.B) voting rights
to shares (total instruments held in issuer
of 8. A) (total of 8.B 1 + (8.A + 8.B) vii
8.B 2)
Resulting 4.9899 4.9899 259,940
situation on the
date on which
threshold was
crossed or reached
Position of 9.9587 9.9587
previous
notification (if
applicable)
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type of Number of voting rightsix % of voting rights
shares
ISIN code (if Direct Indirect Direct Indirect
possible) (DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
GB00B4QVDF07 259,940 4.9899
SUBTOTAL 8. A 259,940 4.9899
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial Expiration Exercise/ Number of voting rights % of voting
instrument datex Conversion Periodxi that may be acquired if rights
the instrument is
exercised/converted.
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R
(1) (b)
Type of Expiration Exercise/ Physical or cash Number of % of voting
financial datex Conversion settlementxii voting rights rights
instrument Period xi
SUBTOTAL 8.B.2
9. Information in relation to the person subject to the notification obligation
(please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural
person or legal entity and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying) issuerxiii
Full chain of controlled undertakings through which the voting rights and/or X
the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entityxiv (please add additional rows as
necessary)
Namexv % of voting rights if % of voting rights Total of both if it
it equals or is higher through financial equals or is higher
than the notifiable instruments if it than the notifiable
threshold equals or is higher threshold
than the notifiable
threshold
Canaccord Genuity 4.9899 4.9899
Group Inc.
Canaccord Genuity 4.9899 4.9899
Wealth Group Holdings
Limited
Canaccord Genuity 4.9899 4.9899
Wealth Group Holdings
(Jersey) Limited
Canaccord Genuity 4.9899 4.9899
Wealth Group Limited
Hargreave Hale Limited 4.9899 4.9899
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will
be held
11. Additional informationxvi
Place of completion BLACKPOOL, ENGLAND
Date of completion 19 JULY 2021
END
(END) Dow Jones Newswires
July 21, 2021 11:27 ET (15:27 GMT)
Bioventix (AQSE:BVXP.GB)
Historical Stock Chart
From Nov 2024 to Dec 2024
Bioventix (AQSE:BVXP.GB)
Historical Stock Chart
From Dec 2023 to Dec 2024